| Nombre del producto |
Blonanserin |
| Nombre en inglés |
Blonanserin; AD 5423; 2-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine; 2-(4-Ethyl-1-piperazinyl)-4-(p-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta(b)pyridine; AD-5423; Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(1-fluorophenyl)-5,6,7,8,9,10-hexahydro-; Cycloocta(b)pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-; 2-(4-ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine; Lonasen; Cycloocta[B]Pyridine, 2-(4-Ethyl-1-Piperazinyl)-4-(4-Fluorophenyl)-5,6,7,8,9,10-Hexahydro- |
| Fórmula molecular |
C23H30FN3 |
| Peso Molecular |
367.5028 |
| InChI |
InChI=1/C23H30FN3/c1-2-26-13-15-27(16-14-26)23-17-21(18-9-11-19(24)12-10-18)20-7-5-3-4-6-8-22(20)25-23/h9-12,17H,2-8,13-16H2,1H3 |
| Número de registro CAS |
132810-10-7 |
| Estructura Molecular |
|
| Densidad |
1.095g/cm3 |
| Punto de ebullición |
540.8°C at 760 mmHg |
| Índice de refracción |
1.557 |
| Punto de inflamación |
280.9°C |
| Presión de vapor |
9.21E-12mmHg at 25°C |
| Símbolos de Peligro |
|
| Códigos de Riesgos |
|
| Descripción de Seguridad |
|
|
